Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
Go back to Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology| American Pallet Leasing, Inc. (NASDAQ: APLS) | Delayed: 41.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.03 | 52 Week High | $0.01 | |||
| Open | $41.03 | 52 Week Low | $0.00 | |||
| Day High | $41.03 | P/E | N/A | |||
| Day Low | $41.03 | EPS | $0.00 | |||
| Volume | 90,994 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 200.26 +0.55 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $199.71 | 52 Week High | $333.65 | |||
| Open | $198.88 | 52 Week Low | $223.02 | |||
| Day High | $201.00 | P/E | 25.64 | |||
| Day Low | $198.42 | EPS | $7.81 | |||
| Volume | 287,847 | |||||
